Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.60
-0.96 (-2.95%)
At close: Mar 28, 2025, 4:00 PM
31.71
+0.11 (0.34%)
After-hours: Mar 28, 2025, 7:56 PM EDT

Avidity Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
10.99.569.229.336.79
Upgrade
Revenue Growth (YoY)
13.98%3.64%-1.09%37.41%192.67%
Upgrade
Cost of Revenue
303.59190.97150.4101.1837.6
Upgrade
Gross Profit
-292.7-181.41-141.18-91.86-30.82
Upgrade
Selling, General & Admin
86.2454.1937.7326.213.46
Upgrade
Operating Expenses
86.2454.1937.7326.213.46
Upgrade
Operating Income
-378.94-235.6-178.91-118.05-44.28
Upgrade
Interest Expense
-----0.21
Upgrade
Interest & Investment Income
56.8823.974.980.10.21
Upgrade
Other Non Operating Income (Expenses)
-0.25-0.59-0.06-0.06-0.08
Upgrade
Pretax Income
-322.3-212.22-174-118.01-44.36
Upgrade
Net Income
-322.3-212.22-174-118.01-44.36
Upgrade
Net Income to Common
-322.3-212.22-174-118.01-44.36
Upgrade
Shares Outstanding (Basic)
11273524122
Upgrade
Shares Outstanding (Diluted)
11273524122
Upgrade
Shares Change (YoY)
52.83%39.97%25.91%91.24%698.49%
Upgrade
EPS (Basic)
-2.89-2.91-3.34-2.85-2.05
Upgrade
EPS (Diluted)
-2.89-2.91-3.34-2.85-2.05
Upgrade
Free Cash Flow
-307.94-123.29-139.09-98.55-38.21
Upgrade
Free Cash Flow Per Share
-2.76-1.69-2.67-2.38-1.76
Upgrade
Operating Margin
-3477.43%-2464.41%-1939.65%-1265.83%-652.38%
Upgrade
Profit Margin
-2957.71%-2219.87%-1886.33%-1265.38%-653.53%
Upgrade
Free Cash Flow Margin
-2825.88%-1289.66%-1507.92%-1056.76%-562.97%
Upgrade
EBITDA
-376.16-233.5-177.53-117.41-43.9
Upgrade
D&A For EBITDA
2.782.11.390.640.37
Upgrade
EBIT
-378.94-235.6-178.91-118.05-44.28
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q